Nearly 15 years after trying an experimental drug on children in Nigeria during a deadly meningitis epidemic, Pfizer Inc. is still battling the legal claims brought by the children’s families; the families are still waiting for some sort of compensation; and the case is still bogged down in pretrial motions.

But as the case drags along in Manhattan federal court, new developments are drawing more attention to it overseas.